DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Nestle India Limited — Actions initiated/taken or orders passed-XBRL

NSE 1 hr ago·11 Sept 2026, 1:36 pm

Nestle India

Nestle India has informed stock exchanges that it has received or taken certain actions, as detailed in a regulatory filing. This update relates to a specific clause under sub-paragraph 20 of the company's reporting requirements.

For investors, this news is primarily a procedural update regarding regulatory compliance. It does not signal any operational crisis or financial distress for the FMCG giant. The company is simply fulfilling its statutory obligations to disclose details of any regulatory interactions or orders it has received or issued.

Investors should wait for the official regulatory filing to understand the nature of the 'action' or 'order' mentioned. Until the specific details are disclosed, there is no indication of any material impact on the company's business or stock performance.